Atlas Trials

Safety and Tolerability of Seroguard Use

Clinical trial NCT03640559 · COMPLETED

Trial details

NCT number
NCT03640559
Sponsor
Pharmasyntez
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adhesion
Start date
2015-05-19
Primary completion
2015-10-04
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.